This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FAZ053

Novartis AG

Drug Names(s): FAZ 053, FAZ-053

Description: FAZ053 is an anti-PD-L1 antibody, blocking a ligand in the PD-1/PD-L1 immune checkpoint axis.


FAZ053 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug